Along with Roche Pharamceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon. Our broad range of innovative diagnostics tests and systems play a pivotal role in the ground-breaking area of integrated healthcare solutions and cover the early detection, targeted screening, evaluation and monitoring of disease. Roche Diagnostics is active in all market segments, from scientific research and clinical laboratory systems to patient self-monitoring.
Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and relentless
commitment to quality, we unlock opportunities that advance innovation and deliver on the promise of a healthier world.
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company’s nCounter® Analysis System, which has been employed in basic and translational research and cited in 500 peer review publications, has also now been applied to diagnostic use with the nCounter Dx Analysis System. The nCounter-based Prosigna™ Breast Cancer Prognostic Gene Signature Assay is marketed for use on the nCounter Dx Analysis System which is FDA 510(k) cleared.
Hologic’s is an independent CRO with over 30 years’ experience in the provision of molecular genetic services and as a MHRA approved QC Testing Laboratory. With a global reach, Hologic’s diversified genomic offering is centred at our Molecular Genetics and Manufacturing facility in Manchester, UK. We offer a broad range of services for biomarker discovery, validation and companion diagnostic development in support of genomic research, clinical trials, and translational research.
Our portfolio of proprietary enabling technologies combined with our team of industry experts and scalable partnering approach, allows us to support all your needs from discovery through commercialization. We offer end-to-end, full-service solutions that include upfront discovery, assay development, clinical testing, regulatory filing, cGMP manufacturing and global product commercialization.
Intuitive Biosciences, a Biotechnology Company based in Middleton, Wisconsin specializing in building multiplex assay solutions that enhance the customer lab experience. Intuitive Biosciences has all the tools and expertise needed to rapidly convert or build new multiplex assays based on customer requirements and needs. The final product is a complete package including components, assay and instrument ready to run in the customer lab… Read More
Diagnostic certainty for every patient is a critical first step in the fight against cancer.
Agilent’s Dako pathology solutions are designed to help hospitals and pathology laboratories around the world make fast and accurate diagnoses. This enables the most effective treatment decisions for cancer patients, ultimately improving patient care and enhancing survival rates.
Almac Diagnostics is a global personalised medicine company, focusing on the discovery, development and commercialisation of complex diagnostic and companion diagnostic tests. Almac Diagnostics offer Pharma and Biotech companies a highly customised Drug CDx partnership approach. Creating tailored solutions, utilising complex biology, we can help differentiate your drug in the marketplace. Our global, state of the art, CLIA-accredited labs in the USA and… Read More
ANGLE is a UK and US based medical diagnostic company. ANGLE’s Parsortix technology enables the capture and harvest of circulating tumour cells from patient blood. The resulting liquid biopsy (simple blood test) provides a powerful tool to deliver personalised cancer care. ANGLE is currently developing its first diagnostic product in the area of ovarian cancer. The Parsortix system has CE Mark regulatory approval in Europe and an FDA approval process is underway in the US.